Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
Rafael José Vieira, N. Pham‐Thi, Josep M. Antó, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 11, pp. 3008-3017.e4
Open Access | Times Cited: 25

Showing 25 citing articles:

Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air®approach
Jean Bousquet, Josep M Antó, Bernardo Sousa‐Pinto, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Patients' values and preferences for health states in allergic rhinitis—An artificial intelligence supported systematic review
Jan Brożek, E Borowiack, Ewelina Sadowska, et al.
Allergy (2024) Vol. 79, Iss. 7, pp. 1812-1830
Open Access | Times Cited: 9
MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 8, pp. 2010-2016.e7
Open Access | Times Cited: 8
Ambient pollen exposure and pollen allergy symptom severity in the EPOCHAL study
Axel Luyten, Alexandra Bürgler, Sarah Glick, et al.
Allergy (2024) Vol. 79, Iss. 7, pp. 1908-1920
Open Access | Times Cited: 7
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report
Jean Bousquet, Mohamed H. Shamji, Josep M. Antó, et al.
Allergy (2023) Vol. 78, Iss. 7, pp. 1758-1776
Open Access | Times Cited: 16
The impact of allergic rhinitis on future educational outcomes: a Danish real-world register study
Signe Vahlkvist, Mercedes Romano Rodriguez, Mikkel Winther Pedersen, et al.
Current Medical Research and Opinion (2025), pp. 1-8
Open Access
Prevalence of allergic rhinitis and its impact on daily life and academic achievement among students of the Syrian Private University
Marah Soukieh, Louei Darjazini Nahas
Research Square (Research Square) (2025)
Closed Access
Efficacy and safety of Chinese patent medicines for allergic rhinitis based on 2020 Chinese Pharmacopoeia: a protocol for systematic review and meta-analysis of randomized controlled trials
Weibo Zhao, Lingyao Kong, Xuehui Wang, et al.
Systematic Reviews (2025) Vol. 14, Iss. 1
Open Access
Impact of allergic symptoms on work productivity in allergic rhinitis: A MASK-air direct patient data study
Rafael José Vieira, Ana Margarida Pereira, Maciej Kupczyk, et al.
Allergology International (2025)
Open Access
ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist
Giovanni Paoletti, Corrado Giua, Alessandro Marti, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 5, pp. 101055-101055
Closed Access
UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan
Jean Bousquet, Bolesław Samoliński, Ігор Петрович Кайдашев, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2581-2595
Open Access | Times Cited: 10
Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper
Oliver Pfaar, Bernardo Sousa‐Pinto, Nikolaos G. Papadopoulos, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2037-2050
Open Access | Times Cited: 3
Embedding patients' values and preferences in guideline development for allergic diseases: The case study of Allergic Rhinitis and its Impact on Asthma 2024
Rafael José Vieira, Bernardo Sousa‐Pinto, Antonio Bognanni, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 3
Protocol for the systematic reviews on the desirable and undesirable effects of pharmacological treatments of allergic rhinitis informing the ARIA 2024 guidelines
Rafael José Vieira, Maria Inês Torres, Antonio Bognanni, et al.
Allergologie select (2024) Vol. 8, Iss. 1, pp. 270-277
Open Access | Times Cited: 3
Impact of allergic rhinitis control on work productivity and costs: a real-world data MASK-air study
Rafael José Vieira, Luís Filipe Azevedo, Ana Margarida Pereira, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 3107-3115.e13
Closed Access | Times Cited: 2
From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe)
Bernardo Sousa‐Pinto, Yuliia Palamarchuk, Lucas Leemann, et al.
Journal of Investigational Allergology and Clinical Immunology (2023) Vol. 34, Iss. 1, pp. 12-19
Open Access | Times Cited: 6
Intranasal antihistamines and corticosteroids in the treatment of allergic rhinitis: a systematic review and meta-analysis protocol
Bernardo Sousa‐Pinto, Rafael José Vieira, Jan Brożek, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076614-e076614
Open Access | Times Cited: 6
Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
Bernardo Sousa‐Pinto, Oliver Pfaar, Jean Bousquet
Allergologie select (2023) Vol. 7, Iss. 1, pp. 47-56
Open Access | Times Cited: 4
The Prevalence and Impact of Allergic Rhinitis on Academic Performance and Quality of Life Among Medical Students in Saudi Arabia
Zohour A Almalki, Ayman Atalla, Fai M Altalhi, et al.
Cureus (2023)
Open Access | Times Cited: 4
The Application of mHealth and Artificial Intelligence to Chronic Rhinitis
Michael J. Marino, Bernardo Sousa‐Pinto, Devyani Lal
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 6, pp. 1490-1492
Closed Access | Times Cited: 1
Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma
Bernardo Sousa‐Pinto, JA Fonseca, Jean Bousquet
Journal of Investigational Allergology and Clinical Immunology (2024) Vol. 34, Iss. 3, pp. 148-156
Open Access | Times Cited: 1
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 1
Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air® app
Jean Bousquet, Alina Gherasim, F. de Blay, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 5
Open Access
Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study
Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, et al.
Drugs in Context (2024) Vol. 13, pp. 1-10
Open Access
Person‐centred care in allergen immunotherapy in a digital era
Chew Lip Ng, De Yun Wang
Allergy (2024) Vol. 79, Iss. 8, pp. 2034-2036
Closed Access
Page 1

Scroll to top